Industry News
How tumor cells transition to invasion revealed by microchip
Aug 19, 2014
Using a microengineered device that acts as an obstacle course for cells, researchers have shed new light on a cellular metamorphosis thought to play a role in tumor cell invasion throughout the body. Read More
In an ecosystem within us, microbes evolved to sway food choices
Aug 19, 2014
Do gut bacteria rule our minds?This image illustrates the relationship between gut bacteria and unhealthy eating. Read More
Mechanism identified that halts progression of abnormal cells into cancer
Aug 19, 2014
Researchers from Boston University School of Medicine (BUSM) report that a tumor suppressor pathway, called the Hippo pathway, is responsible for sensing abnormal chromosome numbers in cells and... Read More
Potential drug therapy for kidney stones identified in mouse study
Aug 19, 2014
Anyone who has suffered from kidney stones is keenly aware of the lack of drugs to treat the condition, which often causes excruciating pain. Read More
New ways to treat solid tumours
Aug 19, 2014
An international team of scientists has shown that an antibody against the protein EphA3, found in the micro-environment of solid cancers, has anti-tumour effects. Read More
An enzyme therapy may prevent skeletal abnormalities associated with the genetic disorder neurofibromatosis type-1
Aug 19, 2014
Vanderbilt investigators have discovered a novel treatment that strengthens bones in neurofibromatosis type-1. Read More
Older patients with limited life expectancy still receiving cancer screenings
Aug 18, 2014
A substantial number of older patients with limited life expectancy continue to receive routine screenings for prostate, breast, cervical and colorectal cancer although the procedures are unlikely... Read More
Tumors shrink following bacteria injection
Aug 18, 2014
Tumors in rats, dogs and one human patient shrank after being injected with spores of a mutant version of a soil bacterium that thrives only in oxygen-poor environments. Read More
NICE rejection of abiraterone before chemotherapy in advanced prostate cancer
Aug 18, 2014
Janssen statement in response to the NICE Final Appraisal Determination (FAD) on the use of Zytiga® (abiraterone acetate) prior to chemotherapyJanssen is extremely disappointed with the... Read More
FDA approves Avastin to treat patients with aggressive and late-stage cervical cancer
Aug 18, 2014
The U.S. Food and Drug Administration today approved a new use for Avastin (bevacizumab) to treat patients with persistent, recurrent or late-stage (metastatic) cervical cancer. Read More
Previous Page Next Page